193 related articles for article (PubMed ID: 19616965)
21. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis.
Schett G; Tohidast-Akrad M; Smolen JS; Schmid BJ; Steiner CW; Bitzan P; Zenz P; Redlich K; Xu Q; Steiner G
Arthritis Rheum; 2000 Nov; 43(11):2501-12. PubMed ID: 11083274
[TBL] [Abstract][Full Text] [Related]
22. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors.
Aeberli D; Seitz M; Jüni P; Villiger PM
Rheumatology (Oxford); 2005 Feb; 44(2):172-5. PubMed ID: 15509629
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis.
Gerards AH; de Lathouder S; de Groot ER; Dijkmans BA; Aarden LA
Rheumatology (Oxford); 2003 Oct; 42(10):1189-96. PubMed ID: 12777636
[TBL] [Abstract][Full Text] [Related]
24. Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis.
Vigna-Pérez M; Abud-Mendoza C; Portillo-Salazar H; Alvarado-Sánchez B; Cuevas-Orta E; Moreno-Valdés R; Baranda L; Paredes-Saharopulos O; González-Amaro R
Clin Exp Immunol; 2005 Aug; 141(2):372-80. PubMed ID: 15996202
[TBL] [Abstract][Full Text] [Related]
25. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
[TBL] [Abstract][Full Text] [Related]
26. Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1beta and glucocorticoids.
Toh ML; Yang Y; Leech M; Santos L; Morand EF
Arthritis Rheum; 2004 Oct; 50(10):3118-28. PubMed ID: 15476200
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis.
Li J; Shen W; Kong K; Liu Z
Scand J Immunol; 2006 Nov; 64(5):515-22. PubMed ID: 17032244
[TBL] [Abstract][Full Text] [Related]
28. Cytokine production of stimulated whole blood cultures in rheumatoid arthritis patients receiving short-term infliximab therapy.
Popa C; Netea MG; Barrera P; Radstake TR; van Riel PL; Kullberg BJ; Van der Meer JW
Cytokine; 2005 Apr; 30(2):72-7. PubMed ID: 15804598
[TBL] [Abstract][Full Text] [Related]
29. IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase.
Kumar S; Votta BJ; Rieman DJ; Badger AM; Gowen M; Lee JC
J Cell Physiol; 2001 Jun; 187(3):294-303. PubMed ID: 11319753
[TBL] [Abstract][Full Text] [Related]
30. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL
Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504
[TBL] [Abstract][Full Text] [Related]
31. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.
Xu H; He Y; Yang X; Liang L; Zhan Z; Ye Y; Yang X; Lian F; Sun L
Rheumatology (Oxford); 2007 Jun; 46(6):920-6. PubMed ID: 17314215
[TBL] [Abstract][Full Text] [Related]
32. T cell activation signals up-regulate p38 mitogen-activated protein kinase activity and induce TNF-alpha production in a manner distinct from LPS activation of monocytes.
Schafer PH; Wang L; Wadsworth SA; Davis JE; Siekierka JJ
J Immunol; 1999 Jan; 162(2):659-68. PubMed ID: 9916683
[TBL] [Abstract][Full Text] [Related]
33. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N
Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214
[TBL] [Abstract][Full Text] [Related]
34. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.
Schuerwegh AJ; van Offel JF; Bridts CH; Stevens WJ; De Clerck LS
J Rheumatol; 2001 Aug; 28(8):1793-9. PubMed ID: 11508581
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of antigen-presenting cell function and stimulation of human peripheral blood mononuclear cells to express an antiinflammatory cytokine profile by the stress protein BiP: relevance to the treatment of inflammatory arthritis.
Corrigall VM; Bodman-Smith MD; Brunst M; Cornell H; Panayi GS
Arthritis Rheum; 2004 Apr; 50(4):1164-71. PubMed ID: 15077298
[TBL] [Abstract][Full Text] [Related]
36. Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression.
Netea MG; Radstake T; Joosten LA; van der Meer JW; Barrera P; Kullberg BJ
Arthritis Rheum; 2003 Jul; 48(7):1853-7. PubMed ID: 12847679
[TBL] [Abstract][Full Text] [Related]
37. IL-2 and IL-10 production by human CD4+T cells is differentially regulated by p38: mode of stimulation-dependent regulation of IL-2.
Veiopoulou C; Kogopoulou O; Tzakos E; Mavrothalassitis G; Mitsias D; Karafoulidou A; Paliogianni F; Moutsopoulos HM; Thyphronitis G
Neuroimmunomodulation; 2004; 11(4):199-208. PubMed ID: 15249725
[TBL] [Abstract][Full Text] [Related]
38. Influence of anti-tumor necrosis factor therapy (Adalimumab) on regulatory T cells and dendritic cells in rheumatoid arthritis.
Dombrecht EJ; Aerts NE; Schuerwegh AJ; Hagendorens MM; Ebo DG; Van Offel JF; Bridts CH; Stevens WJ; De Clerck LS
Clin Exp Rheumatol; 2006; 24(1):31-7. PubMed ID: 16539816
[TBL] [Abstract][Full Text] [Related]
39. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
40. Effects of dexamethasone on lymphocyte proliferation and cytokine production in rheumatoid arthritis.
De A; Blotta HM; Mamoni RL; Louzada P; Bertolo MB; Foss NT; Moreira AC; Castro M
J Rheumatol; 2002 Jan; 29(1):46-51. PubMed ID: 11824970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
